| Lenscrafters #972 | |
| 600 E Northern Lights Blvd, Anchorage, Alaska 99503 | |
| (907) 258-6920 |
| Name | Lenscrafters #972 |
|---|---|
| Organization Name | Luxottica Of America Inc |
| Location | 600 E Northern Lights Blvd, Anchorage, Alaska 99503 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (907) 258-6920 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The report offers cost estimates for a range of approaches that would head off a 29.4 percent reduction in Medicare physician payments scheduled to kick in Jan. 1, 2012. Meanwhile, in other news, a plan to curb the overuse of costly medical imaging demonstrates the difficulties posed by attempting even small changes in the health insurance program for seniors.
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
Bioengineers from Queen Mary University of London have shown for the first time that lithium chloride, a common drug used to treat mental health disorders, could offer an effective treatment against osteoarthritis by disrupting the length of the cells' antennae called primary cilia.
Dr. David Blumenthal, MD, MPP, national coordinator for health information technology in the Office of the National Coordinator for Health Information Technology today announced an additional $12 million in new technical support assistance to help critical access hospitals and rural hospitals adopt and become meaningful users of certified health information technology.
The United States Food and Drug Administration ("FDA") is cracking down on the importation of unapproved new drugs with regards to personal use. Import Alert #66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S." ("IA 66-41") was most recently published on September 23, 2010. IA 66-41 contains a Red List, a list of importers whose products are automatically detained for FDA violations, of over 400 firms on the charge of importing misbranded unapproved new drugs. Benjamin England, founder of FDAImports.com, LLC and former FDA Compliance Officer, attorney, and Food and Drug Law expert states that "This Import Alert has been expanded to include importers and products of drugs imported strictly for personal use rather than just targeting foreign shippers, which is FDA's normal M.O."
› Verified 1 days ago
| NPI Number | 1316092471 |
| Organization Name | LUXOTTICA OF AMERICA INC. |
| Doing Business As | LENSCRAFTERS #972 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 600 E Northern Lights Blvd, Anchorage, AK 99503 |
| Phone Number | 907-258-6920 |
News Archive
The report offers cost estimates for a range of approaches that would head off a 29.4 percent reduction in Medicare physician payments scheduled to kick in Jan. 1, 2012. Meanwhile, in other news, a plan to curb the overuse of costly medical imaging demonstrates the difficulties posed by attempting even small changes in the health insurance program for seniors.
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
Bioengineers from Queen Mary University of London have shown for the first time that lithium chloride, a common drug used to treat mental health disorders, could offer an effective treatment against osteoarthritis by disrupting the length of the cells' antennae called primary cilia.
Dr. David Blumenthal, MD, MPP, national coordinator for health information technology in the Office of the National Coordinator for Health Information Technology today announced an additional $12 million in new technical support assistance to help critical access hospitals and rural hospitals adopt and become meaningful users of certified health information technology.
The United States Food and Drug Administration ("FDA") is cracking down on the importation of unapproved new drugs with regards to personal use. Import Alert #66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S." ("IA 66-41") was most recently published on September 23, 2010. IA 66-41 contains a Red List, a list of importers whose products are automatically detained for FDA violations, of over 400 firms on the charge of importing misbranded unapproved new drugs. Benjamin England, founder of FDAImports.com, LLC and former FDA Compliance Officer, attorney, and Food and Drug Law expert states that "This Import Alert has been expanded to include importers and products of drugs imported strictly for personal use rather than just targeting foreign shippers, which is FDA's normal M.O."
› Verified 1 days ago
News Archive
The report offers cost estimates for a range of approaches that would head off a 29.4 percent reduction in Medicare physician payments scheduled to kick in Jan. 1, 2012. Meanwhile, in other news, a plan to curb the overuse of costly medical imaging demonstrates the difficulties posed by attempting even small changes in the health insurance program for seniors.
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
Bioengineers from Queen Mary University of London have shown for the first time that lithium chloride, a common drug used to treat mental health disorders, could offer an effective treatment against osteoarthritis by disrupting the length of the cells' antennae called primary cilia.
Dr. David Blumenthal, MD, MPP, national coordinator for health information technology in the Office of the National Coordinator for Health Information Technology today announced an additional $12 million in new technical support assistance to help critical access hospitals and rural hospitals adopt and become meaningful users of certified health information technology.
The United States Food and Drug Administration ("FDA") is cracking down on the importation of unapproved new drugs with regards to personal use. Import Alert #66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S." ("IA 66-41") was most recently published on September 23, 2010. IA 66-41 contains a Red List, a list of importers whose products are automatically detained for FDA violations, of over 400 firms on the charge of importing misbranded unapproved new drugs. Benjamin England, founder of FDAImports.com, LLC and former FDA Compliance Officer, attorney, and Food and Drug Law expert states that "This Import Alert has been expanded to include importers and products of drugs imported strictly for personal use rather than just targeting foreign shippers, which is FDA's normal M.O."
› Verified 1 days ago
Procare Home Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4215 Credit Union Drive, Anchorage, Alaska 99503 Phone: (907) 274-0770 | |
Bernies Pharmacy Inc Type: Pharmacy Location: 4100 Lake Otis Pkwy, Anchorage, Alaska 99508 Phone: (907) 562-2138 | |
Geneva Woods Medset Pharmacy Type: Medicare Supplier Location: 501 W International Airport Rd, Anchorage, Alaska 99518 Phone: (907) 562-2414 | |
Cvs Pharmacy #17436 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 150 W 100th Ave, Anchorage, Alaska 99515 Phone: (907) 267-7501 | |
Alaska Cvs Pharmacy Llc Type: Community/Retail Pharmacy Location: 1200 N Muldoon Rd, Anchorage, Alaska 99504 Phone: (907) 269-2101 |